Boston Scientific Corporation (BSX)

Healthcare • Medical - Devices

Beobachten

$76,06

Price

-0,30%

Change

112,80 Mrd. $

Market Cap

P/E Ratio

Neumann-Score Stock Analysis

out of 100

Beobachten

Valuation??/100

Profitability??/100

Growth??/100

Unlock Score Details

Become a member and get access to all analyses.

Become a Member

About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, ...

CEO

Michael F. Mahoney

Employees

53.000

Country